|
|
|
|
|
Product Name
|
Von Willebrand Factor antibody (FITC)
|
| |
See all Von Willebrand Factor antibodies (24)...
|
|
Product type
|
Primary antibodies
|
|
Description
|
Sheep polyclonal to Von Willebrand Factor (FITC)
|
|
Immunogen
|
Human Von Willebrand Factor Antigen prepared from citrated human plasma. Greater than 95% purity by SDS-PAGE.
|
|
Reacts with
(species key)
|
Hu
|
|
Specificity
|
The unconjugated immunoglobulin gives no arcs when tested by immunoelectrophoresis against human serum. Identity has been confirmed by double diffusion (Ouchterlony) against von Willebrand Factor and an anti-von Willebrand Factor of known specificity.
|
|
Tested applications
(see key)
|
IHC-Fr
|
|
|
Abreviews
|
|
|
|
Application notes
(see key)
|
Recommended dilutions IHC-Fr: 1/50 - 1/100.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Positive control
(see definition)
|
Direct on frozen sections of human tonsil.
|
|
Cellular localization
|
Secreted. Localized to storage granules.
|
|
Research areas
|
Stem Cells >> Endothelial Progenitors >> Endothelial Markers Cardiovascular >> Blood >> Coagulation >> Regulatory Cardiovascular >> Blood >> Coagulation >> Extrinsic Cardiovascular >> Blood >> Platelets Cardiovascular >> Blood >> Serum Proteins
|
|
Relevance
|
Von Willebrand Factor (VWF) was previously known as Factor VIII related antigen. VWF is synthesized exclusively by endothelial cells and megakaryocytes, and stored in the intracellular granules or constitutively secreted into plasma. This glycoprotein functions as both an antihemophilic factor carrier and a platelet vessel wall mediator in the blood coagulation system. Important in the maintenance of homeostasis, it participates in platelet vessel wall interactions by forming a noncovalent complex with coagulation factor VIII at the site of vascular injury. The Von Willebrand factor has functional binding domains to platelet glycoprotein Ib, glycoprotein IIb/IIIa, collagen and heparin. Mutations in this gene or deficiencies in this protein result in Von Willebrand's disease. VWD is characterized by frequent bleeding (gingival, minor skin quantitative lacerations, menorrhagia, etc.).
|
|
|
|
|
Database links
|
The links below go to external sites and will open in a new browser window
|
|
Raised in
|
Sheep
|
|
Clonality
|
Polyclonal
|
|
Isotype
|
IgG
|
|
Purity
|
Immunogen affinity purified
|
|
Conjugation notes
|
Fluorescein Isothiocyante (FITC)
|
|
Storage buffer
|
PBS, pH 7.2, sodium azide, 0.1% Material safety datasheet (MSDS) for this product: Sodium Azide MSDS
|
|
Form
|
Liquid
|
|
Conjugation
|
Fluorescein
|
|
Concentration
|
10.000 mg/ml
|
|
Storage instructions
|
Store at +4°C.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Von Willebrand Factor antibody (FITC) is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
References for Von Willebrand Factor antibody (FITC) (ab8822)
|
|
This product has been used in:
Wang W et al. Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney. Am J Physiol Renal Physiol 294:F739-47 (2008). PubMed: 18216145
If you publish research using ab8822 please let us know so that we can cite the reference on this datasheet.
|
| |
|
Search PubMed (MEDLINE) for references to Von Willebrand Factor
|
| |
Von Willebrand Factor antibody (FITC) - more information
|
Customer reviews (feedback) regarding Von Willebrand Factor antibody (FITC) |
Customer FAQs regarding Von Willebrand Factor antibody (FITC) |
Protocols for Von Willebrand Factor antibody (FITC) |
Price and availability of products related to Von Willebrand Factor antibody (FITC) |
| |
Von Willebrand Factor antibody (FITC) - related products:
|
|
|
| |
Von Willebrand Factor antibody (FITC) - other tools:
|
Contact Abcam with a Technical Enquiry about Von Willebrand Factor antibody (FITC) |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"